Daptomycin

Daptomycin is a naturally occurring cyclic lipopeptide antibiotic. It is highly effective in treating complicated skin infections and bacteremia caused by Gram-positive bacteria.

SKU: 103060-53-3 Category: Tags: ,
Description
Daptomycin is, furthermore, a premier pharmaceutical Active Pharmaceutical Ingredient (API) supplied by Zyntex for the clinical, hospital, and life sciences research sectors. This pale yellow to light brown solid (CAS 103060-53-3) is distinguished by having a unique mechanism of action compared to other antibiotic classes. In addition, it possesses a cyclic lipopeptide structure derived from Streptomyces roseosporus. Therefore, it is extensively utilized as a primary therapeutic agent for complicated skin and soft tissue infections (cSSTI) and as a high-potential treatment for MRSA-related bacteremia.

Comprehensive Product Overview

In the field of infectious disease control, the ability to neutralize multidrug-resistant pathogens is a major advantage. Daptomycin is specifically selected because it can disrupt the bacterial cell membrane without penetrating the cytoplasm. For instance, it exhibits rapid, concentration-dependent bactericidal activity against a broad range of Gram-positive organisms. Consequently, it facilitates the management of severe infections with lower risks of resistance development compared to traditional glycopeptides. As a result, Zyntex ensures that our high-purity Daptomycin is stored under strictly temperature-controlled conditions to prevent molecular degradation.

Moreover, the pharmaceutical-grade Daptomycin provided by Zyntex is a vital component in the development of injectable formulations and lyophilized powders. This application allows for the creation of high-efficacy intravenous therapies, undoubtedly pushing the boundaries of what is possible in acute care medicine. At the same time, its role in treating right-sided infective endocarditis is highly valued by global healthcare providers. In short, our product serves as a dependable “precision-antibiotic” for companies focusing on both life-saving treatments and advanced clinical research.

Recently, scientific interest has surged regarding the use of Daptomycin in combination therapies to overcome vancomycin-resistant enterococci (VRE). Because of this, Zyntex offers specialized analytical documentation and high-purity batches to provide reliable outcomes in pharmaceutical formulation. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that balances therapeutic potency with rigorous regulatory compliance. To conclude, our commitment to pharmaceutical excellence ensures that your manufacturing processes—whether in drug development or clinical trials—achieve the highest levels of purity and therapeutic yield.

Key Industrial Applications

This high-potency cyclic lipopeptide is specifically vital in the following four sectors:

🧪 Clinical Microbiology

A potent agent for Gram-positive inhibition; thus enabling the study of membrane-active antimicrobial mechanisms.

💊 Hospital Pharmacy

Key ingredient for IV formulations; consequently vital for the next generation of acute care anti-infectives.

🔬 Drug Formulation R&D

Investigated for novel delivery systems; undoubtedly essential for improving antibiotic bioavailability and safety.

🩹 Dermatology Research

Used in the study of complicated skin infections; specifically helping to combat resistant staphylococcal strains.

Technical Specifications

ParameterStandard Value
Product NameDaptomycin
Assay / PurityMin. 98.0% (HPLC)
Molecular FormulaC72H101N17O26
CAS Number103060-53-3

⚠️ Safety Warning: Daptomycin must be handled with care by professional personnel. It is sensitive to environmental conditions; therefore, it must be stored under refrigeration ($2^{\circ}C$ to $8^{\circ}C$) and protected from light to maintain pharmaceutical activity.